These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12385857)

  • 41. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia.
    Wilson LF; Page AN; Dunn NA; Pandeya N; Protani MM; Taylor RJ
    Maturitas; 2013 Dec; 76(4):370-6. PubMed ID: 24113278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hormone replacement therapy use over a decade in an Australian population.
    MacLennan AH; Wilson DH; Taylor AW
    Climacteric; 2002 Dec; 5(4):351-6. PubMed ID: 12626214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevalence of use of hormone replacement therapy in women participating in a breast cancer screening program].
    Martínez-Pino I; Puig T; Quintana MJ; Solà J; Bonfill X
    Med Clin (Barc); 2010 Apr; 134(10):439-42. PubMed ID: 20045126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hormone replacement therapy, body mass index and asthma in perimenopausal women: a cross sectional survey.
    Gómez Real F; Svanes C; Björnsson EH; Franklin KA; Gislason D; Gislason T; Gulsvik A; Janson C; Jögi R; Kiserud T; Norbäck D; Nyström L; Torén K; Wentzel-Larsen T; Omenaas E
    Thorax; 2006 Jan; 61(1):34-40. PubMed ID: 16244093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HRT and breast cancer: impact on population risk and incidence.
    Coombs NJ; Taylor R; Wilcken N; Boyages J
    Eur J Cancer; 2005 Aug; 41(12):1775-81. PubMed ID: 16087330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hormone replacement therapy in the peri-menopausal and post menopausal period: more than half of the women were treated for more than one year].
    Tobi H; van den Berg PB; Brouwers JR; de Jong-van den Berg LT
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1853-5. PubMed ID: 14533498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women.
    Barinas-Mitchell E; Cushman M; Meilahn EN; Tracy RP; Kuller LH
    Am J Epidemiol; 2001 Jun; 153(11):1094-101. PubMed ID: 11390329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
    Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
    Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Personal use of postmenopausal hormone replacement therapy by women physicians in the United States.
    McNagny SE; Wenger NK; Frank E
    Ann Intern Med; 1997 Dec; 127(12):1093-6. PubMed ID: 9412312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of hormone replacement therapy and user's characteristics: a community survey in Japan.
    Nagata C; Matsushita Y; Shimizu H
    Maturitas; 1996 Nov; 25(3):201-7. PubMed ID: 8981337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Duration of hormone replacement therapy, breast tumour size and grade in a screening programme.
    Gertig DM; Erbas B; Fletcher A; Amos A; Kavanagh AM
    Breast Cancer Res Treat; 2003 Aug; 80(3):267-73. PubMed ID: 14503799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral symptoms at menopause--the role of hormone replacement therapy.
    Tarkkila L; Linna M; Tiitinen A; Lindqvist C; Meurman JH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Sep; 92(3):276-80. PubMed ID: 11552144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of hormone replacement therapy on C-reactive protein: population-based data.
    Primatesta P; Falaschetti E; Poulter NR
    J Cardiovasc Risk; 2003 Feb; 10(1):57-60. PubMed ID: 12569237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in intra-abdominal fat in early postmenopausal women: effects of hormone use.
    Gower BA; Muñoz J; Desmond R; Hilario-Hailey T; Jiao X
    Obesity (Silver Spring); 2006 Jun; 14(6):1046-55. PubMed ID: 16861610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.
    DeSancho MT; Dorff T; Rand JH
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):534-8. PubMed ID: 20581664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lifestyle factors and choice of hormone replacement therapy among Danish nurses.
    Hundrup YA; Thoning H; Obel EB; Rasmussen NK; Philip J
    Scand J Public Health; 2002; 30(1):47-53. PubMed ID: 11928833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Psychological aspects of decision-making by women about using hormone replacement therapy].
    Olejek A
    Wiad Lek; 2000; 53(1-2):92-7. PubMed ID: 10806928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The associations of hormone replacement therapy and preventive practices in minority women.
    Ganesan K; Teklehaimanot S; Asuncion M
    J Natl Med Assoc; 2005 Jan; 97(1):68-73. PubMed ID: 15719874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Has the impact of hormone replacement therapy on health-related quality of life been undervalued?
    Tosteson AN; Gabriel SE; Kneeland TS; Moncur MM; Manganiello PD; Schiff I; Ettinger B; Melton LJ
    J Womens Health Gend Based Med; 2000 Mar; 9(2):119-30. PubMed ID: 10746515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.